Patent details

EP2101569 Title: CRYSTALLINE SOLID RASAGILINE BASE

Basic Information

Publication number:
EP2101569
PCT Application Number:
PCT/US/2007/025583
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078629060
PCT Publication Number:
WO/2008/076348
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE SOLID RASAGILINE BASE
French Title of Invention:
RASAGILINE BASE SOLIDE CRISTALLINE
German Title of Invention:
KRISTALLINE FESTE RASAGILIN-BASE
SPC Number:

Dates

Filing date:
13/12/2007
Grant date:
19/10/2011
EP Publication Date:
19/10/2011
PCT Publication Date:
26/06/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/09/2009
EP B1 Publication Date:
19/10/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/12/2016
Expiration date:
13/12/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/12/2007
 
 

Name:
Teva Pharmaceutical Industries Ltd.
Address:
5 Basel Street P.O. Box 3190, 49131 Petach-Tikva, Israel (IL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/12/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KOLTAI Tamas
Address:
Israel (IL)

2

Name:
FRENKEL Anton
Address:
Israel (IL)

Priority

Priority Number:
875011 P
Priority Date:
14/12/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A01N 33/02;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
21/12/2015
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages